Aptamers with high affinity and specificity for certain targets have rapidly become a novel
class of targeted ligands applicated in drug delivery. Based on the excellent characteristics …

Prostate cancer is among most malignant tumors around the world and this urological tumor
can be developed as result of genomic mutations and their accumulation during progression …

Cancer cases have reached an all-time high in the current era. Thus, there is a need to
develop advanced therapeutic methods that can effectively inhibit the proliferation of …

Prostate cancer (PCa) is a malignant disorder of prostate gland being asymptomatic in early
stages and high metastatic potential in advanced stages. The chemotherapy and surgical …

Abstract Copper diethyldithiocarbamate [Cu (DDC) 2] is a promising anticancer agent.
However, its poor water solubility is a significant obstacle to clinical application. In previous …

Class III β-tubulin (βIII-tubulin) is frequently overexpressed in human tumors and is
associated with resistance to microtubule-targeting agents, tumor aggressiveness, and poor …

Combination therapy against cancer has gained increasing attention because it can help to
target multiple pathways to tackle oncologic progression and improve the limited antitumor …

Given the global prevalence of prostate cancer in men, it is crucial to explore more effective
treatment strategies. Recently, immunotherapy has emerged as a promising cancer …

Discovering novel cancer therapies has attracted extreme interest in the last decade. In this
regard, multidrug resistance (MDR) to chemotherapies is a key challenge in cancer …

The treatment of colorectal cancer is always a major challenge in the field of cancer
research. The number of estimated new cases of colorectal cancer worldwide in 2020 is 1 …